Home › Pressione alta › Arizona
Studi clinici su Pressione alta nello stato di Arizona
12 studi su Pressione alta cercano partecipanti presso sedi nello stato di Arizona.
Città nello stato di Arizona
Testo ufficiale dello studio (inglese)
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- Retension Clinical Site, Tucson
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07142356A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Banner - University Medical Center Tucson, Tucson
In reclutamento
Età da 18 a 85 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07214376A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Arizona Clinical Trials - Chandler, Chandler
- Elite Clinical Studies, Phoenix
- Clinical Research Institute of Arizona, LLC, Sun City West
- e altri 3
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Care Access - 801 South Power Road, Mesa, Mesa
- Absolute Clinical Research, Phoenix
- Synexus Clinical Research US, Inc./Orange Grove Family Practice, Tucson
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Surprise
- Research Site, Tucson
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06742723THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- HonorHealth, Scottsdale
In reclutamento
Età da 22 a 75 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Chandler
- Clinical Trial Site, Gilbert
- Clinical Trial Site, Mesa
- e altri 8
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT07181109Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH
- Banner University Medical Center South, Tucson
- UAHS Center for Sleep, Circadian, & Neuroscience Research Department of Medicine, University of Arizona, Tucson
In reclutamentoVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07799961Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Phoenix
- Vanda Investigative Site, Tempe
- Vanda Investigative Site, Tucson
In reclutamentoFase 2
Età da 18 a 65 · Tutti i sessi · Aggiornato il 27 feb 2026 · NCT07090161bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
- University of Arizona, Tucson
In reclutamento
Età 60 e oltre · Tutti i sessi · Aggiornato il 15 ott 2025 · NCT06307574CardioCare Quest: A Co-created Game for Improving Hypertension Treatment Compliance in Arizona
- School of Informatics Computing and Cyber Systems, Flagstaff
- Northern Arizona University, Flagstaff
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 giu 2025 · NCT06487637Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.